Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Sugar Land, TX
SEC filing record 1 source field available
Fiscal year end
31 December
Tvardi Therapeutics, Inc. has filed 809 SEC EDGAR filings since 06 Dec 2005

SEC filing history

Showing 776-800 of 804 matching filings.

Per page
25
Current page
32
4

FORM 4 SUBMISSION

Filing date
31 Jan 2014
Reporting date
30 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
31 Jan 2014
Reporting date
30 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
31 Jan 2014
Reporting date
30 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
31 Jan 2014
Reporting date
30 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
31 Jan 2014
Reporting date
30 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
31 Jan 2014
Reporting date
30 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
CERTNAS File 001-36279

AUTO-GENERATED PAPER DOCUMENT

Filing date
30 Jan 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-192230

EFFECT filing

Filing date
30 Jan 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
30 Jan 2014
Reporting date
30 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
30 Jan 2014
Reporting date
30 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
30 Jan 2014
Reporting date
30 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
30 Jan 2014
Reporting date
30 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
30 Jan 2014
Reporting date
30 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
30 Jan 2014
Reporting date
30 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
30 Jan 2014
Reporting date
30 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
30 Jan 2014
Reporting date
30 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
30 Jan 2014
Reporting date
30 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
28 Jan 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
28 Jan 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12B File 001-36279

8-A12B

Filing date
27 Jan 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-192230

AMENDMENT NO. 2 TO FORM S-1

Filing date
17 Jan 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-192230

AMENDMENT NO. 1 TO FORM S-1

Filing date
31 Dec 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
30 Dec 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
21 Nov 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
08 Nov 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .